Frontier Bio
PrivateLast Round
Crowdfunding
Mar 4, 2026
Total Funding Raised
$1.62M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Frontier Bio is a biotechnology company that develops lab-grown human tissues and vascular grafts to provide an alternative to animal testing and address the organ transplant shortage.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Frontier Bio Comparables
Compare Frontier Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FluidForm Bio | 84% | |
| Vivodyne | 82% | |
| Hesperos Inc. | 78% |
Frontier Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Mar 4, 2026 | ||||
| Seed | Aug 29, 2025 | ||||
| Accelerator | May 1, 2025 | ||||
| Grant | Aug 15, 2021 | ||||
| Seed | May 14, 2020 | ||||
Accelerator | May 2, 2019 |
Key People
Founding team and executive leadership
Frontier Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartX | Seed |
| Brinc | Accelerator |
| Boutique Venture Partners | Seed |
| Break Off Capital | Seed |
| America's Seed Fund | Grant |
| Alchemist Accelerator | Seed, Accelerator |
| Immortal Dragons | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
Won 'Best Paper' award at the 50th Annual VESS meeting.
- Apr 9, 2026
Received Best Paper Award at the VESS Annual Meeting.
Recent news
Latest coverage and updates
- is_developingJul 2, 2026
Frontier Bio Corporation is developing human-based tissue platforms.
Frontier Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Frontier Bio's valuation, stock price, and market status.
Is Frontier Bio a public or private company?
Frontier Bio is a private company.
What is the current stock price of Frontier Bio?
Frontier Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Frontier Bio worth (valuation)?
Valuation information for Frontier Bio is not publicly available.
Can I buy Frontier Bio stock?
Frontier Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Frontier Bio's last funding round?
Frontier Bio's most recent funding round was Strategic on August 29, 2025.
Who are the main investors in Frontier Bio?
Key investors in Frontier Bio include Immortal Dragons, National Science Foundation.
Will Frontier Bio IPO soon?
No public IPO plans have been announced for Frontier Bio.
How can I track Frontier Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Frontier Bio's secondary market activity and sign up for updates.